Truly transformative healthcare companies often solve "boring" but fundamental problems. Instead of tackling surface-level symptoms (e.g., appointment booking), the best founders dig deep to fix the complex, underlying infrastructure issues of the healthcare system, creating a durable competitive moat.

Generic nutrition apps fail to address the needs of people with specific chronic conditions. The real HealthTech opportunity is in building verticalized AI platforms that act as a central 'project manager' for one ailment, like GERD or migraines, integrating data and providing targeted advice.

Startups often fail to displace incumbents because they become successful 'point solutions' and get acquired. The harder path to a much larger outcome is to build the entire integrated stack from the start, but initially serve a simpler, down-market customer segment before moving up.

Pitches for an "Uber of healthcare" fundamentally misunderstand the industry. Healthcare isn't a simple, one-off transaction like a taxi ride; it's a complex, ongoing human relationship that requires continuous connection, which purely transactional models fail to provide.

Two dominant strategies are winning. Companies can either be the absolute best at one specific thing (e.g., musculoskeletal care, women's health) or build a platform that aggregates these best-in-class solutions into a seamless 'digital front door' for insurers and corporations.

A key expansion strategy is moving 'upper funnel' from treating specific, acute conditions to offering a holistic, preventative platform. For Hims & Hers, adding diagnostics ('Labs') created a new entry point for users to understand their overall health, not just solve one problem.

By verticalizing infrastructure to offer at-home diagnostic testing for free or at cost, a healthcare company can build the world's largest health dataset. This loss leader provides immense value to patients, builds trust, and creates a powerful and defensible customer acquisition channel for high-margin treatments.

Focusing on a single, narrow application limits long-term growth. By designing a scalable platform from the outset, MedTech companies can adapt their core technology to other procedures and markets, ensuring future viability and expansion opportunities.

In healthcare, the user, recommender, and payer are often different entities. A clinically effective product can easily fail if it's not inserted into the right point in the value chain where a stakeholder is both willing and incentivized to pay for it.